Opuntia ficus-indica leaf clinical trials
Also written Litramine.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2012
How each study uses opuntia ficus-indica leaf is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2012 | 2 |
| 2017 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses opuntia ficus-indica leaf is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Efficacy and Safety of Litramine in 1 Year Weight Loss StudyCompletedNot applicableInQpharm GroupNCT03227276Written as Litramine
- A Study of the Effect of Bran, Psyllium and Nopal on Intestinal Water Content Using Magnetic Resonance ImagingCompletedNot applicableUniversity of NottinghamNCT03263065Written as Nopal
- Litramine for Weight LossCompletedNot applicableInQpharm GroupNCT02488356Written as Litramine
- Litramine in Weight MaintenanceCompletedPhase 4InQpharm GroupNCT01505387Written as Litramine